Table of Contents

1 Report Overview

• 1.1 Research Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Eculizumab Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Plasma Exchange
  • 1.3.3 Plasma Infusion
• 1.4 Market Segment by Application
  • 1.4.1 Global Eculizumab Market Share by Application (2019-2025)
  • 1.4.2 PNH
  • 1.4.3 aHUS
  • 1.4.4 Other
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Production and Capacity Analysis
  • 2.1.1 Global Eculizumab Production Value 2014-2025
  • 2.1.2 Global Eculizumab Production 2014-2025
  • 2.1.3 Global Eculizumab Capacity 2014-2025
  • 2.1.4 Global Eculizumab Marketing Pricing and Trends
• 2.2 Key Producers Growth Rate (CAGR) 2019-2025
  • 2.2.1 Global Eculizumab Market Size CAGR of Key Regions
  • 2.2.2 Global Eculizumab Market Share of Key Regions
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Capacity and Production by Manufacturers
  • 3.1.1 Global Eculizumab Capacity by Manufacturers
  • 3.1.2 Global Eculizumab Production by Manufacturers
• 3.2 Revenue by Manufacturers
  • 3.2.1 Eculizumab Revenue by Manufacturers (2014-2019)
  • 3.2.2 Eculizumab Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Eculizumab Market Concentration Ratio (CR5 and HHI)
• 3.3 Eculizumab Price by Manufacturers
• 3.4 Key Manufacturers Eculizumab Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Eculizumab Market
• 3.6 Key Manufacturers Eculizumab Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Production and Production Value for Each Type
  • 4.1.1 Plasma Exchange Production and Production Value (2014-2019)
  • 4.1.2 Plasma Infusion Production and Production Value (2014-2019)
• 4.2 Global Eculizumab Production Market Share by Type
• 4.3 Global Eculizumab Production Value Market Share by Type
• 4.4 Eculizumab Ex-factory Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Eculizumab Consumption by Application

6 Production by Regions

• 6.1 Global Eculizumab Production (History Data) by Regions 2014-2019
• 6.2 Global Eculizumab Production Value (History Data) by Regions
• 6.3 United States
  • 6.3.1 United States Eculizumab Production Growth Rate 2014-2019
  • 6.3.2 United States Eculizumab Production Value Growth Rate 2014-2019
  • 6.3.3 Key Players in United States
  • 6.3.4 United States Eculizumab Import & Export
• 6.4 European Union
  • 6.4.1 European Union Eculizumab Production Growth Rate 2014-2019
  • 6.4.2 European Union Eculizumab Production Value Growth Rate 2014-2019
  • 6.4.3 Key Players in European Union
  • 6.4.4 European Union Eculizumab Import & Export
• 6.5 China
  • 6.5.1 China Eculizumab Production Growth Rate 2014-2019
  • 6.5.2 China Eculizumab Production Value Growth Rate 2014-2019
  • 6.5.3 Key Players in China
  • 6.5.4 China Eculizumab Import & Export
• 6.6 Rest of World
  • 6.6.1 Japan
  • 6.6.2 Korea
  • 6.6.3 India
  • 6.6.4 Southeast Asia

7 Eculizumab Consumption by Regions

• 7.1 Global Eculizumab Consumption (History Data) by Regions
• 7.2 United States
  • 7.2.1 United States Eculizumab Consumption by Type
  • 7.2.2 United States Eculizumab Consumption by Application
• 7.3 European Union
  • 7.3.1 European Union Eculizumab Consumption by Type
  • 7.3.2 European Union Eculizumab Consumption by Application
• 7.4 China
  • 7.4.1 China Eculizumab Consumption by Type
  • 7.4.2 China Eculizumab Consumption by Application
• 7.5 Rest of World
  • 7.5.1 Rest of World Eculizumab Consumption by Type
  • 7.5.2 Rest of World Eculizumab Consumption by Application
  • 7.5.1 Japan
  • 7.5.2 Korea
  • 7.5.3 India
  • 7.5.4 Southeast Asia

8 Company Profiles

• 8.1 Alexion
  • 8.1.1 Alexion Company Details
  • 8.1.2 Company Description and Business Overview
  • 8.1.3 Production and Revenue of Eculizumab
  • 8.1.4 Eculizumab Product Introduction
  • 8.1.5 Alexion Recent Development

9 Market Forecast

• 9.1 Global Market Size Forecast
  • 9.1.1 Global Eculizumab Capacity, Production Forecast 2019-2025
  • 9.1.2 Global Eculizumab Production Value Forecast 2019-2025
• 9.2 Market Forecast by Regions
  • 9.2.1 Global Eculizumab Production and Value Forecast by Regions 2019-2025
  • 9.2.2 Global Eculizumab Consumption Forecast by Regions 2019-2025
• 9.3 United States
  • 9.3.1 Production and Value Forecast in United States
  • 9.3.2 Consumption Forecast in United States
• 9.4 European Union
  • 9.4.1 Production and Value Forecast in European Union
  • 9.4.2 Consumption Forecast in European Union
• 9.5 China
  • 9.5.1 Production and Value Forecast in China
  • 9.5.2 Consumption Forecast in China
• 9.6 Rest of World
  • 9.6.1 Japan
  • 9.6.2 Korea
  • 9.6.3 India
  • 9.6.4 Southeast Asia
• 9.7 Forecast by Type
  • 9.7.1 Global Eculizumab Production Forecast by Type
  • 9.7.2 Global Eculizumab Production Value Forecast by Type
• 9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis

• 10.1 Value Chain Analysis
• 10.2 Sales Channels Analysis
  • 10.2.1 Eculizumab Sales Channels
  • 10.2.2 Eculizumab Distributors
• 10.3 Eculizumab Customers

11 Opportunities & Challenges, Threat and Affecting Factors

• 11.1 Market Opportunities
• 11.2 Market Challenges
• 11.3 Porter's Five Forces Analysis

12 Key Findings

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details

In 2019, the market size of Eculizumab is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Eculizumab.

This report studies the global market size of Eculizumab, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Eculizumab production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Alexion
...

Market Segment by Product Type
Plasma Exchange
Plasma Infusion

Market Segment by Application
PNH
aHUS
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Eculizumab status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Eculizumab manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Eculizumab are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025